Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juanda Leo Hartono

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Alimentary Pharmacology & Therapeutics|October 23, 2019
Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's diseaseJoyce Wing Yan Mak, Whitney Tang, Terry Cheuk Fung Yip, et al.
The Journal of Infection|August 9, 2024
Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individualsAmy May Lin Quek, Suqing Wang, Ooiean Teng, et al.
Cancers|April 3, 2021
Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control StudyPei Yi Lee, Kellynn Qi Xuan Oen, Grace Rui Si Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal AnalysesMichael J Buie, Joshua Quan, Joseph W Windsor, et al.
Nature|April 30, 2025
Global evolution of inflammatory bowel disease across epidemiologic stagesLindsay Hracs, Joseph W Windsor, Julia Gorospe, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Alimentary Pharmacology & Therapeutics|October 23, 2019
Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's diseaseJoyce Wing Yan Mak, Whitney Tang, Terry Cheuk Fung Yip, et al.
The Journal of Infection|August 9, 2024
Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individualsAmy May Lin Quek, Suqing Wang, Ooiean Teng, et al.
Cancers|April 3, 2021
Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control StudyPei Yi Lee, Kellynn Qi Xuan Oen, Grace Rui Si Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal AnalysesMichael J Buie, Joshua Quan, Joseph W Windsor, et al.
Nature|April 30, 2025
Global evolution of inflammatory bowel disease across epidemiologic stagesLindsay Hracs, Joseph W Windsor, Julia Gorospe, et al.
Pageof 2